Roivant Sciences Newsroom

Roivant Sciences Analyst Ratings

BenzingaNov 13 14:01 ET

TD Cowen Maintains Roivant Sciences(ROIV.US) With Buy Rating

Moomoo NewsNov 13 08:31 ET

H.C. Wainwright Maintains Roivant Sciences(ROIV.US) With Buy Rating, Maintains Target Price $18

Moomoo NewsNov 13 06:32 ET

TD Cowen Maintains Roivant Sciences(ROIV.US) With Buy Rating

Moomoo NewsNov 12 19:32 ET

TD Cowen Keeps Their Buy Rating on Roivant Sciences (ROIV)

TipRanksNov 12 19:16 ET

Roivant Sciences (ROIV) Receives a Buy From TD Cowen

TipRanksNov 8 08:34 ET

TD Cowen Maintains Roivant Sciences(ROIV.US) With Buy Rating

Moomoo NewsNov 8 08:32 ET

Leerink Partners Maintains Roivant Sciences(ROIV.US) With Buy Rating

Moomoo NewsOct 21 08:31 ET

Goldman Sachs Maintains Roivant Sciences(ROIV.US) With Buy Rating

Moomoo NewsSep 19 08:33 ET

Strong Buy Rating for Roivant Sciences Backed by Strategic Dermavant Divestiture and Promising Clinical Pipeline

TipRanksSep 19 08:27 ET

H.C. Wainwright Maintains Roivant Sciences(ROIV.US) With Buy Rating, Maintains Target Price $18

Moomoo NewsSep 19 06:33 ET

Analysts Offer Insights on Healthcare Companies: Progyny (PGNY) and Roivant Sciences (ROIV)

TipRanksSep 19 06:25 ET

Roivant Sciences Analyst Ratings

BenzingaSep 19 06:22 ET

TD Cowen Maintains Roivant Sciences(ROIV.US) With Buy Rating

Moomoo NewsSep 18 18:32 ET

Jefferies Maintains Roivant Sciences(ROIV.US) With Buy Rating, Raises Target Price to $18

Moomoo NewsSep 16 08:31 ET

BofA Securities Maintains Roivant Sciences(ROIV.US) With Hold Rating, Maintains Target Price $12.5

Moomoo NewsSep 11 09:31 ET

TD Cowen Maintains Roivant Sciences(ROIV.US) With Buy Rating

Moomoo NewsSep 11 09:31 ET

A Quick Look at Today's Ratings for Roivant Sciences(ROIV.US), With a Forecast Between $12.5 to $18

Moomoo NewsSep 11 09:00 ET

Roivant Sciences Analyst Ratings

BenzingaSep 11 07:45 ET

Buy Rating Affirmed on Roivant Sciences: Promising Drug Pipeline and Strategic Acquisitions

TipRanksSep 11 06:19 ET